|
Pfizer Japan Selects Cognos ReportNetT for Enterprise Reporting
Pharmaceutical leader chooses Cognos ReportNet
for multilingual support, pure Web, next-generation architecture
TOKYO, JAPAN AND BURLINGTON, MA, September 10, 2003Cognos (Nasdaq: COGN; TSX: CSN), the world leader in business intelligence (BI) and corporate performance management, today announced Pfizer Japan has chosen Cognos ReportNet for its enterprise reporting requirements. Initially, sales and marketing staff in Pfizer Japan will use Cognos ReportNet to access key financial, customer and market information.
Based on a rigorous competitive evaluation, Pfizer Japan selected Cognos ReportNet for its pure Web architecture, extensive multilingual support, and multi-data source, multi-query capabilities. A Cognos ReportNet beta tester, Pfizer Japan worked extensively with Cognos, conducting a broad range of solution testing.
"Pfizer Japan was extremely impressed by Cognos' extensive focus on the Japanese market with Cognos ReportNet. Offering full Unicode support, Cognos ReportNet gives users the ability to consume reports in the language of their choice. With unprecedented ease of use and drag-and-drop authoring, Cognos ReportNet gives our hundreds of business users a consolidated, self-service, on-demand environment, giving them rapid access to key corporate performance information," said Scott Morrison, Member of the Board, Vice President, Business Technology-Japan, Pfizer Japan. "By allowing our business users to perform ad-hoc queries and author reports on the fly, Cognos ReportNet will free our IT staff from the burden of creating end user reports, allowing them to focus their time more strategically and dramatically reducing our total cost of ownership."
Designed to scale to 100s of 1,000s of users, Cognos ReportNet solution draws upon Cognos reporting and query leadership, delivering the next revolution in reporting. Cognos ReportNet is fully integrated within the Cognos Enterprise BI solution, including flexible scorecards, dashboards, powerful industry-leading OLAP analysis, event detection and alerting, and data integration.
"The global response to Cognos ReportNet has been incredible. Built from the ground up with the latest Web Service technologies, Cognos ReportNet offers unprecedented scalability, report authoring and multilingual support. It is an honor to work with prestigious organizations like Pfizer Japan in the worldwide launch of Cognos ReportNet," said Rob Ashe, president and COO, Cognos.

###
Cognos and the Cognos logo are trademarks or registered trademarks of Cognos Incorporated in the United States and/or other countries. All other names are trademarks or registered trademarks of their respective companies.
Note to Editors:
Copies of previous Cognos press releases and Corporate and product information are available on Cognos' Web site at http://www.cognos.com, and at PR Newswire's site at http://www.prnewswire.com.
|